Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization

Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy has been shown to improve outcomes among patients with congestive heart failure, diabetes, or renal dysfunction. These patients are also at risk for the development of hyperkalemia (HK), often leading to down-titration and/or discontinua...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Nihar R., Rowan, Christopher G., Alvarez, Paula J., Fogli, Jeanene, Toto, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946143/
https://www.ncbi.nlm.nih.gov/pubmed/31910208
http://dx.doi.org/10.1371/journal.pone.0226844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946143/
https://www.ncbi.nlm.nih.gov/pubmed/31910208
http://dx.doi.org/10.1371/journal.pone.0226844

Ejemplares similares